Jervell-Lange Nielsen Syndrome: Clinical Trials

5 trials for Jervell-Lange Nielsen Syndrome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 active not recruiting. 1 Phase 2, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1
Phase 41Completed 1

Follow this condition Literature Review of Jervell-Lange Nielsen Syndrome trials Research Report on Jervell-Lange Nielsen Syndrome

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Diltiazem in Jervell and Lange-Nielsen Syndrome
diltiazem - Jervell and Lange Nielsen Syndrome
Phase 4CompletedVanderbilt University Medical Center12024-10-162025-10-14
Baby Detect : Genomic Newborn Screening
Congenital Adrenal Hyperplasia, Familial Hyperinsulinemic Hypoglycemia 1
CompletedCentre Hospitalier Universitaire de Liege68242022-09-012025-08-12
Early Check: Expanded Screening in Newborns
Confirmatory Testing - Spinal Muscular Atrophy, Fragile X Syndrome
Active not recruitingRTI International300002018-10-152026-07-01
Influence of Progesterone Administration on Drug-Induced QT Interval Lengthening
Progesterone, Placebo, Ibutilide - Prolonged QT Interval in EKG and Sudden Death
Phase 2CompletedIndiana University192013-04-012015-10-30
The Long QT Syndrome in Pregnancy
Long QT Syndrome
CompletedUniversity of British Columbia122007-06-012011-04-14

Narrower conditions

3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency (2)  ·  Acidemia, isovaleric (2)  ·  Anemia, Sickle Cell (2)  ·  Argininosuccinic Aciduria (2)  ·  Ataxia with vitamin E deficiency (2)  ·  Basal ganglia disease, biotin-responsive (2)  ·  Beta ketothiolase deficiency (2)  ·  Biotinidase Deficiency (2)  ·  Brown-Vialetto-Van Laere syndrome (2)  ·  Carbamoyl-Phosphate Synthase I Deficiency Disease (2)  ·  Carnitine palmitoyl transferase 1A deficiency (2)  ·  Carnitine palmitoyl transferase 2 deficiency (2)  ·  Carnitine-Acylcarnitine Translocase Deficiency (2)  ·  Citrullinemia (2)

Broader conditions

Arrhythmias, Cardiac (5)  ·  Cardiac Conduction System Disease (5)  ·  Cardiovascular Abnormalities (5)  ·  Cardiovascular Diseases (5)  ·  Congenital Abnormalities (5)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (5)  ·  Heart Defects, Congenital (5)  ·  Heart Diseases (5)  ·  Pathologic Processes (5)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Long QT Syndrome (3)  ·  Abnormalities, Multiple (2)  ·  Albinism (2)  ·  Amino Acid Metabolism, Inborn Errors (2)  ·  Anemia (2)

Interventions

Diltiazem (1)  ·  Progesterone (1)  ·  ibutilide (1)

Sponsors

Centre Hospitalier Universitaire de Liege (1)  ·  Indiana University (1)  ·  RTI International (1)  ·  University of British Columbia (1)  ·  Vanderbilt University Medical Center (1)

Countries

United States (3)  ·  Belgium (1)  ·  Canada (1)

Top investigators

Curt Scharfe, MD, PhD (1)  ·  Elizabeth Drake, MD (1)  ·  James E Tisdale, BSc, PharmD (1)  ·  Joanne Douglas, MD (1)  ·  Laurent Servais (1)  ·  Marla Kiess, MD (1)  ·  Prince J Kannankeril, MD, MSCI (1)  ·  Roanne Preston, MD (1)  ·  Stanley Tung, MD (1)

Results publications

PMID 31315600, PMID 35142618